Erik Kinnman Vice President, Chief Strategic Officer and Head of Investor Relations & Public Affairs E-mail
+46 8 697 20 00
2010-08-31 15:30 New number of shares and votes in Swedish Orphan Biovitrum AB (publ)
2010-08-26 08:30 Swedish Orphan Biovitrum's Kineret® has Received Orphan Drug Designation in the USA
2010-07-20 08:30 Interim financial report for the period 1st April to 30th June, 2010
2010-07-13 10:00 Presentation of Biovitrum's Interim Report January - June, 2010
2010-07-12 08:30 Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting Hemophilia B Therapy at the World Federation of Hemophilia Congress
2010-07-09 15:30 Biogen Idec and Swedish Orphan Biovitrum Announce Decision to Advance Long-Lasting Hemophilia A Therapy into a Registrational Trial
2010-07-06 08:30 Swedish Orphan Biovitrum and Dongbao announce Commercial Alliance for the Chinese and European markets
2010-06-21 16:00 Change of company name for Biovitrum AB (publ)
2010-05-11 13:30 Swedish Orphan Biovitrum and Biomodels to develop assay for mucositis risk in cancer treatment
2010-05-06 08:30 Swedish Orphan Biovitrum presents first positive Kiobrina® clinical phase II data
2010-04-30 11:45 New number of shares and votes in Biovitrum AB (publ)
2010-04-27 19:30 Resolutions from Biovitrum's AGM
2010-04-27 08:45 Kiobrina® clinical phase II results trigger milestone payment from Swedish Orphan Biovitrum
2010-04-27 08:30 Interim financial report for the period 1 January to 31 March, 2010
2010-04-21 17:31 Presentation of Biovitrum's Interim Report January - March, 2010
2010-04-21 08:30 Swedish Orphan Biovitrum has decided to move Kiobrina® into phase III development
2010-04-15 08:30 Swedish Orphan Biovitrum and Pharming sign Rhucin® distribution agreement
2010-04-13 14:00 Biovitrum's Annual Report 2009 now available online
2010-04-08 08:30 Swedish Orphan Biovitrum launches Willfact® under its distribution agreement with LFB BIOMEDICAMENTS
2010-04-06 14:00 Swedish Orphan Biovitrum makes payment to vendors of Cambridge Biotechnology Limited
2010-04-01 08:30 Swedish Orphan Biovitrum extends Cyanokit® cooperation with Merck Serono
2010-03-26 08:30 Notice to the Annual General Meeting of Biovitrum AB (publ), Tuesday April 27, 2010
2010-03-23 08:30 Swedish Orphan Biovitrum updates European Kepivance® label
2010-03-12 08:30 Swedish Orphan Biovitrum has agreed to an additional Kineret® drug campaign with Amgen
2010-02-18 08:30 Biovitrum Full Year Report 2009
2010-02-18 08:00 Biogen Idec and Swedish Orphan Biovitrum Update Hemophilia Partnership Agreement
2010-02-12 15:00 Presentation of Biovitrum's Interim Report October - December and Full Year Report for 2009
2010-01-29 11:30 New number of shares and votes in Biovitrum AB (publ)
2010-01-25 08:30 Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Acting Hemophilia B Therapy
2010-01-14 12:00 Biovitrum AB (publ) completes the acquisition of Swedish Orphan International Holding AB and resolves on an issue in kind
2010-01-08 08:30 Biovitrum ABs (publ) rights issue fully subscribed
You can also subscribe to press releases and financial reports.
